Literature DB >> 17846250

Pathology of inhalational anthrax infection in the african green monkey.

N A Twenhafel1, E Leffel, M L M Pitt.   

Abstract

There is a critical need for an alternative nonhuman primate model for inhalational anthrax infection because of the increasingly limited supply and cost of the current model. This report describes the pathology in 12 African green monkeys (AGMs) that succumbed to inhalational anthrax after exposure to a low dose (presented dose 200-2 x 10(4)colony-forming units [cfu]) or a high dose (presented dose 2 x 10(4)-1 x 10(7) cfu) of Bacillus anthracis (Ames strain) spores. Frequent gross lesions noted in the AGM were hemorrhage and edema in the lung, mediastinum, and mediastinal lymph nodes; pleural and pericardial effusions; meningitis; and gastrointestinal congestion and hemorrhage. Histopathologic findings included necrohemorrhagic lymphadenitis of mediastinal, axillary, inguinal, and mesenteric lymph nodes; mediastinal edema; necrotizing splenitis; meningitis; and congestion, hemorrhage, and edema of the lung, mesentery, mesenteric lymph nodes, gastrointestinal tract, and gonads. Pathologic changes in AGMs were remarkably similar to what has been reported in rhesus macaques and humans that succumbed to inhalational anthrax; thus, AGMs could serve as useful models for inhalation anthrax studies.

Entities:  

Mesh:

Year:  2007        PMID: 17846250     DOI: 10.1354/vp.44-5-716

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  25 in total

1.  MyD88-dependent signaling protects against anthrax lethal toxin-induced impairment of intestinal barrier function.

Authors:  Shu Okugawa; Mahtab Moayeri; Michael A Eckhaus; Devorah Crown; Sharmina Miller-Randolph; Shihui Liu; Shizuo Akira; Stephen H Leppla
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence.

Authors:  Amy Jenkins; Christopher Cote; Nancy Twenhafel; Tod Merkel; Joel Bozue; Susan Welkos
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling.

Authors:  Narcis Ioan Popescu; Alanson Girton; Tarea Burgett; Kessa Lovelady; K Mark Coggeshall
Journal:  Blood Adv       Date:  2019-08-27

4.  A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors:  Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

5.  Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.

Authors:  Steven B Yee; Joshua M Hatkin; David N Dyer; Steven A Orr; M Louise M Pitt
Journal:  Comp Med       Date:  2010-12       Impact factor: 0.982

6.  Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection.

Authors:  David E Lowe; Stephen M C Ernst; Christine Zito; Jason Ya; Ian J Glomski
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

7.  Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.

Authors:  Thi-Sau Migone; Sally Bolmer; John Zhong; Al Corey; Daphne Vasconcelos; Matthew Buccellato; Gabriel Meister
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

8.  Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax.

Authors:  Cynthia A Rossi; Melanie Ulrich; Sarah Norris; Douglas S Reed; Louise M Pitt; Elizabeth K Leffel
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

9.  Anthrax of the gastrointestinal tract and oropharynx: CT findings.

Authors:  Huseyin Ozdemir; Kutbettin Demirdag; Tulin Ozturk; Ercan Kocakoc
Journal:  Emerg Radiol       Date:  2009-06-05

10.  Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Authors:  Vladimir Savransky; Daniel C Sanford; Emily Syar; Jamie L Austin; Kevin P Tordoff; Michael S Anderson; Gregory V Stark; Roy E Barnewall; Crystal M Briscoe; Laurence Lemiale-Biérinx; Sukjoon Park; Boris Ionin; Mario H Skiadopoulos
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.